Simon has over 30 years experience in academic and industry research. As Head of the Innovative Medicines Unit at Grünenthal Innovation, Simon led a team responsible for in-licensing molecules and delivering them to Clinical proof of concept. Prior to Grünenthal, Simon worked for AstraZeneca where he was lead for both small molecule and antibody projects, with a track record of delivery from Lead Identification through to clinical validation.  He is currently Director of Pharmacology at TherapeutAix UG.